Logo image of LOVE.CA

CANNARA BIOTECH INC (LOVE.CA) Stock Fundamental Analysis

Canada - TSX-V:LOVE - CA13765U2002 - Common Stock

1.73 CAD
+0.04 (+2.37%)
Last: 9/16/2025, 7:00:00 PM
Fundamental Rating

5

LOVE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 5 industry peers in the Personal Care Products industry. LOVE has a great financial health rating, but its profitability evaluates not so good. LOVE is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year LOVE was profitable.
LOVE had a positive operating cash flow in the past year.
In multiple years LOVE reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: LOVE reported negative operating cash flow in multiple years.
LOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFLOVE.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

LOVE's Return On Assets of 9.12% is amongst the best of the industry. LOVE outperforms 100.00% of its industry peers.
With an excellent Return On Equity value of 15.74%, LOVE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
ROA 9.12%
ROE 15.74%
ROIC N/A
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
LOVE.CA Yearly ROA, ROE, ROICLOVE.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

LOVE has a Profit Margin of 15.15%. This is amongst the best in the industry. LOVE outperforms 100.00% of its industry peers.
Looking at the Gross Margin, with a value of 14.02%, LOVE is doing worse than 60.00% of the companies in the same industry.
LOVE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 15.15%
GM 14.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
LOVE.CA Yearly Profit, Operating, Gross MarginsLOVE.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

More info and screens

7

2. Health

2.1 Basic Checks

LOVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
LOVE has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, LOVE has more shares outstanding
The debt/assets ratio for LOVE has been reduced compared to a year ago.
LOVE.CA Yearly Shares OutstandingLOVE.CA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LOVE.CA Yearly Total Debt VS Total AssetsLOVE.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.07 indicates that LOVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
LOVE's Altman-Z score of 2.07 is fine compared to the rest of the industry. LOVE outperforms 80.00% of its industry peers.
The Debt to FCF ratio of LOVE is 2.92, which is a good value as it means it would take LOVE, 2.92 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LOVE (2.92) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that LOVE is not too dependend on debt financing.
The Debt to Equity ratio of LOVE (0.41) is better than 100.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 2.92
Altman-Z 2.07
ROIC/WACCN/A
WACC7.33%
LOVE.CA Yearly LT Debt VS Equity VS FCFLOVE.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

LOVE has a Current Ratio of 2.43. This indicates that LOVE is financially healthy and has no problem in meeting its short term obligations.
LOVE has a better Current ratio (2.43) than 80.00% of its industry peers.
A Quick Ratio of 1.01 indicates that LOVE should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.01, LOVE perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 1.01
LOVE.CA Yearly Current Assets VS Current LiabilitesLOVE.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 189.86% over the past year.
The Revenue has grown by 33.04% in the past year. This is a very strong growth!
LOVE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 108.26% yearly.
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.26%
Revenue 1Y (TTM)33.04%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%39.85%

3.2 Future

LOVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.50% yearly.
The Revenue is expected to grow by 19.04% on average over the next years. This is quite good.
EPS Next YN/A
EPS Next 2Y52.16%
EPS Next 3Y42.5%
EPS Next 5YN/A
Revenue Next Year27.9%
Revenue Next 2Y22.09%
Revenue Next 3Y19.04%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
LOVE.CA Yearly Revenue VS EstimatesLOVE.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
LOVE.CA Yearly EPS VS EstimatesLOVE.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 0.05 0.1 0.15 0.2

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 10.18, the valuation of LOVE can be described as reasonable.
Based on the Price/Earnings ratio, LOVE is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.20, LOVE is valued rather cheaply.
Industry RankSector Rank
PE 10.18
Fwd PE N/A
LOVE.CA Price Earnings VS Forward Price EarningsLOVE.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

LOVE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LOVE is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.73
EV/EBITDA N/A
LOVE.CA Per share dataLOVE.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

LOVE's earnings are expected to grow with 42.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y52.16%
EPS Next 3Y42.5%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for LOVE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANNARA BIOTECH INC

TSX-V:LOVE (9/16/2025, 7:00:00 PM)

1.73

+0.04 (+2.37%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)07-28 2025-07-28
Earnings (Next)11-24 2025-11-24
Inst Owners0.13%
Inst Owner ChangeN/A
Ins Owners27.72%
Ins Owner ChangeN/A
Market Cap158.17M
Analysts80
Price Target3.06 (76.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.18
Fwd PE N/A
P/S 1.54
P/FCF 9.73
P/OCF 7.76
P/B 1.6
P/tB 1.6
EV/EBITDA N/A
EPS(TTM)0.17
EY9.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.18
FCFY10.27%
OCF(TTM)0.22
OCFY12.88%
SpS1.12
BVpS1.08
TBVpS1.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.12%
ROE 15.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 15.15%
GM 14.02%
FCFM 15.87%
ROA(3y)3.63%
ROA(5y)-2.7%
ROE(3y)6.49%
ROE(5y)-3.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.07%
GM growth 5Y-41.26%
F-Score8
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 2.92
Debt/EBITDA N/A
Cap/Depr 66.23%
Cap/Sales 4.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 104.74%
Current Ratio 2.43
Quick Ratio 1.01
Altman-Z 2.07
F-Score8
WACC7.33%
ROIC/WACCN/A
Cap/Depr(3y)228.25%
Cap/Depr(5y)410.31%
Cap/Sales(3y)22.24%
Cap/Sales(5y)120%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)189.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.26%
EPS Next YN/A
EPS Next 2Y52.16%
EPS Next 3Y42.5%
EPS Next 5YN/A
Revenue 1Y (TTM)33.04%
Revenue growth 3Y68.19%
Revenue growth 5Y108.26%
Sales Q2Q%39.85%
Revenue Next Year27.9%
Revenue Next 2Y22.09%
Revenue Next 3Y19.04%
Revenue Next 5YN/A
EBIT growth 1Y33.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3Y60.25%
EBIT Next 5YN/A
FCF growth 1Y228.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3771.44%
OCF growth 3YN/A
OCF growth 5YN/A